Hemocue (b)(4) received a complaint stating that 1 box of hemocue glucose 201 microcuvettes lacked the label.This was detected at a warehouse and the product was not delivered to an end customer, ie there was no patient involved.The box was returned to hemocue (b)(4) for investigation.It could be verified that the label on the box was missing.The box contains 4 separate primary packages of 25 microcuvettes each, all labels on the primary packages (with the same information as on the box label) were in place.During the investigation it was also found that the package insert (instructions for use), that should have been inside the box, was missing.Hemocue (b)(4) has not had any indication that this has occurred previously.An ncr has been opened to investigate the issue and to implement corrections.A capa will be initiated to investigate the root cause of the problem.
|